[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
date : 6/26/2024
Tags: NCDs, Precision Cancer Medicine
![[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/ncd-pcm-20240620-1-top-PXL_20240620_061249805.MP_-scaled-1.jpg)
Non-communicable diseases (NCDs), including cancer, are gaining prominence as significant health threats in low and middle-income countries (LMICs). However, they still lack sufficient traction and investment. Since its launch in 2017 as a Union for International Cancer Control (UICC) initiative and its registration as an independent Swiss foundation in 2019, City Cancer Challenge (C/Can) has been supporting cities worldwide in their efforts to enhance access to equitable and quality cancer care. This event showcased C/Can’s innovative approach to cancer care in developing countries through case studies and provide an opportunity to discuss future collaboration opportunities with Japanese cancer and NCD stakeholders through networking sessions.
[Event Overview]
- Date & Time: Thursday, June 20, 2024, from 15:00 to 17:00 JST
- Format: In-Person (no virtual attendance available)
- Venue: Global Business Hub Tokyo
(Grand Cube 3F, Otemachi Financial City, 1-9-2, Otemachi, Chiyoda-ku, Tokyo, 100-0004 JAPAN) - Language: Japanese and English, with simultaneous interpretation
- Participation fee: Free
- Co-host: City Cancer Challenge (C/Can), Health and Global Policy Institute (HGPI)
[Program] (Titles omitted; in no particular order)
15:00-15:05 | Opening Remarks |
![]() |
|
15:05-15:10 | Explanatory Introduction |
![]() |
|
15:10-15:30 | Keynote Speech “Current Status of Cancer Care in Developing Countries and the C/Can Model” |
![]() |
|
15:30-16:00 | Discussion “Voices from the Frontline and Expectations for Japan” |
(All speakers and attendees at the venue)
|
|
16:00-16:05 |
Remarks |
![]() |
|
16:05-16:15 | Q&A |
16:15-17:00 | Networking Session |
About City Cancer Challenge (C/Can)
Since its launch in 2017 as a Union for International Cancer Control (UICC) initiative and its registration as an independent Swiss foundation in 2019, City Cancer Challenge (C/Can) has been supporting cities worldwide in their efforts to enhance access to equitable and quality cancer care. Cancer is the second leading cause of premature death globally, with over 10 million cancer deaths in 2020. Low-and middle-income countries account for seven out of every ten deaths from cancer and the impact of these premature deaths further strains economies. By implementing tailored solutions, countries have the potential to save thousands of lives each year in an effective, sustainable, and scalable manner. C/Can has developed and implemented an innovative model that empowers local stakeholders such as policymakers, hospitals managers, healthcare professionals, academics, civil society representatives and patients to evaluate, plan and implement practical and sustainable solutions to improve cancer care at city level. For C/Can, cities offer a distinct environment to drive innovation in cancer care, which can be expanded to a national level. C/Can is present in 14 cities across Africa, Asia, Europe and Latin America. The global network continues to expand, with an open application process launched in 2023 to on-board new cities in 2025.
Top Research & Recommendations Posts
- [Policy Recommendations] Cancer Control Project “Policy Recommendations on Addressing Regional Disparities in Breast Cancer Care” (January 31, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Discussion Points] Intractable & Rare Diseases Project Discussion Paper “Intractable & Rare Diseases 2025: 10 Years After the Passing of the Intractable Diseases Act, Toward a Co-created Future” (Mar 28, 2025)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Dementia Project Information Packet for Local Government Officials “Dementia Policies for Our City: Taking the First Step in Promoting Future Measures for Dementia” (March 17, 2025)
- [Public Comment Submission] “2050 Tokyo Strategy: Making Tokyo Even Better (Draft)” (March 3, 2025)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
Featured Posts
-
2025-03-26
[Registration Open] (Webinar) The 132nd HGPI Seminar “Considering the Ideal Evidence-Based Immunization and Vaccination Policies” (April 25, 2025)
-
2025-04-02
[Registration Open] Public Event “The Patient and Citizen Lived Experience Forum 2025” (May 17, 2025)
-
2025-04-17
[Registration Open] (Webinar) The 134th HGPI Seminar “Understanding Evidence-Based Dietary Guidelines: Leveraging the Dietary Reference Intakes for Japanese” (May 28, 2025)